Drug Trial Radar · NCT02964260
RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Last checked: Nov 20, 2026Latest source record: May 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
410
Planned (sponsor's estimate)
Start
May 2016
Primary completion
Dec 2022
Study completion Dec 2022
Sponsor
- Lead sponsor
- Sun Yat-sen UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- First Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Third Affiliated Hospital, Sun Yat-Sen University; Sixth Affiliated Hospital, Sun Yat-sen University; Guangdong Provincial People's Hospital
- First posted
- Nov 16, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study intends to evaluate the efficacy and safety of Transarterial embolization (TAE) simultaneously combined with thermal ablation for large hepatocellular carcinoma (HCC). Half participants will receive TAE simultaneously combined with thermal ablation and the other half receive TACE sequentially combined with thermal ablation, which is a conventional treatment for HCC patients.
Conditions
- Hepatocellular Carcinoma, Adult
Interventions
Chemotherapy drugDrug
Doxorubicin/Platinum agents
Embolic agentsDrug
Lipiodol/Gelatin sponge/PVA/Blank microspheres
SimultaneouslyProcedure
1-3 days
SequentiallyProcedure
1 month
AblationDevice
Radiofrequency ablation/Microwave ablation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survivalTime frame: 3 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.